88886
9-(Bromomethyl)acridine
BioReagent, suitable for fluorescence, ≥97.0% (HPLC)
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C14H10BrN
化学文摘社编号:
分子量:
272.14
UNSPSC Code:
12352200
NACRES:
NA.32
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
159526
产品名称
9-(Bromomethyl)acridine, BioReagent, suitable for fluorescence, ≥97.0% (HPLC)
InChI
1S/C14H10BrN/c15-9-12-10-5-1-3-7-13(10)16-14-8-4-2-6-11(12)14/h1-8H,9H2
SMILES string
BrCc1c2ccccc2nc3ccccc13
InChI key
MZFYKBHQWLWIBI-UHFFFAOYSA-N
product line
BioReagent
assay
≥97.0% (HPLC)
form
powder
mp
160-165 °C
fluorescence
λex 335 nm; λem 469 nm in 0.1 M phosphate pH 7.0 (after derivatization with glutathione)
suitability
suitable for fluorescence
Analysis Note
In addition to the emission maximum at 447 nm, there are lower maxima at 468 and 413 nm.
Other Notes
HPLC derivatizing agent for fluorescent labeling of carboxylic acids, e.g. fatty acids
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Wakako Tsuzuki et al.
The Analyst, 127(5), 669-673 (2002-06-26)
For the purpose of deducing the digestive behavior of dietary fat in the digestive organs, a fluorimetric method for the measurement of hydrolysis by porcine pancreatic lipase was performed using intermediate- and long- acyl chain glycerides as substrates. Insoluble glycerides
F A van der Horst et al.
Journal of chromatography, 500, 443-452 (1990-02-02)
The on-line use of micellar phase-transfer catalysis is described for the automated reversed-phase high-performance liquid chromatographic (RP-HPLC) determination of free fatty acids in plasma; minimum manual sample handling is involved. After diluting plasma ten-fold with the aqueous micellar system, which
K. Akasaka et al.
Analytical Letters, 20, 1581-1581 (1987)
Yi-Shan Li et al.
Talanta, 218, 121143-121143 (2020-08-17)
Dipeptidyl peptidase 4 (DPP-4) inhibitors are incretin-based medications used as oral antidiabetic agents for the treatment of type 2 diabetes. However, DPP-4 inhibitors produce side effects like acute pancreatitis, upper respiratory tract infection, nasopharyngitis, urinary tract infection, serious allergies, cardiovascular
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持